Clinical trials: Immunosuppression After Liver Transplantation
Adherence Intervention Post Transplantation
Improving ImmunoSuppression Adherence After Liver or Kidney Transplantation
Indication: liver (LT) or kidney Transplantation (KT) Objectives: to measure medication adherence in liver or kidney transplant patients with and without multilevel intervention programme over time Trial Design: prospective…
- Trial name
- ISALK (NCT04207125)
- Testing
- Multilevel psychotherapeutic intervention programme
- Where
- Austria
- Volunteers
- 150 people
- Sponsor
- Medical University of Graz
Liver Transplantation
Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
Recurrence after liver transplantation for hepatocellular carcinoma (HCC) represents an important cause of mortality for this surgical population.
- Trial name
- NCT02995096
- Testing
- Pre-treatment, Sirolimus based immunosuppression
- Volunteers
- 23,124 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet